Memantine Hydrochloride

Memantine Hydrochloride

2.9 Low risk

Memantine Hydrochloride & Squamous cell carcinoma

61.5%

of users reported Squamous cell carcinoma

75.0%

also reported Hospitalization

100.0%

are women

Most common medical consequences

Hospitalization

75.0%

Severe reaction

25.0%

Have you experienced any negative side effects from this medication?

Memantine Hydrochloride: general information

Most common side effects (2)

Most commonly affected ages

10 - 19 years

18.5%

20 - 29 years

<0.1%

30 - 39 years

<0.1%

40 - 49 years

<0.1%

50 - 59 years

18.5%

60 - 69 years

<0.1%

70 - 79 years

35.2%

80 - 89 years

27.8%

On this page